.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Novartis
Julphar
Cipla
Medtronic
Covington
Express Scripts
QuintilesIMS
Federal Trade Commission
McKinsey

Generated: November 20, 2017

DrugPatentWatch Database Preview

Alpharma Us Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.



Summary for Alpharma Us Pharms

US Patents:0
Tradenames:43
Ingredients:40
NDAs:61
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms
TETRACYCLINE HYDROCHLORIDE
tetracycline hydrochloride
SUSPENSION;ORAL060633-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
SERAX
oxazepam
CAPSULE;ORAL015539-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
SYRUP;ORAL070497-001Apr 25, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
FLURANDRENOLIDE
flurandrenolide
LOTION;TOPICAL087203-001Apr 29, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
MYKINAC
nystatin
CREAM;TOPICAL062387-001Jul 29, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
MYKINAC
nystatin
OINTMENT;TOPICAL062731-001Sep 22, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
LOTION;TOPICAL087191-001Sep 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
HYDROCORTISONE
hydrocortisone
LOTION;TOPICAL087317-001Jun 7, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
ISOETHARINE HYDROCHLORIDE
isoetharine hydrochloride
SOLUTION;INHALATION087101-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
PROCHLORPERAZINE
prochlorperazine edisylate
CONCENTRATE;ORAL087153-001Jun 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma Us Pharms
SERAX
oxazepam
CAPSULE;ORAL015539-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alpharma Us Pharms
SERAX
oxazepam
CAPSULE;ORAL015539-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alpharma Us Pharms
SERAX
oxazepam
CAPSULE;ORAL015539-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Mallinckrodt
AstraZeneca
QuintilesIMS
McKinsey
Argus Health
Cerilliant
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot